287 related articles for article (PubMed ID: 7504401)
21. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
Chelstrom LM; Finnegan D; Uckun FM
Leuk Lymphoma; 1992 May; 7(1-2):79-86. PubMed ID: 1282065
[TBL] [Abstract][Full Text] [Related]
22. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
23. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
[TBL] [Abstract][Full Text] [Related]
24. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
25. Adhesion molecules, endogenous granulocyte colony-stimulating factor levels and replating capacity of progenitors in autoimmune neutropenia of childhood.
Perdikogianni Ch; Dimitriou H; Stiakaki E; Markaki EA; Kalmanti M
Acta Paediatr; 2003 Nov; 92(11):1277-83. PubMed ID: 14696847
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S
Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor.
Okamura J; Yokoyama M; Tsukimoto I; Komiyama A; Sakurai M; Imashuku S; Miyazaki S; Ueda K; Hanawa Y; Takaku F
Pediatr Hematol Oncol; 1992; 9(3):199-207. PubMed ID: 1381941
[TBL] [Abstract][Full Text] [Related]
28. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis.
Zuppa AA; Girlando P; Florio MG; Cota F; Romagnoli C; Tortorolo G
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):131-6. PubMed ID: 11950479
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
30. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
Matsuzaki G; Li XY; Ohyama Y; Nomoto K
Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
[TBL] [Abstract][Full Text] [Related]
32. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
Rabinowitz J; Petros WP; Stuart AR; Peters WP
Blood; 1993 May; 81(9):2452-9. PubMed ID: 7683220
[TBL] [Abstract][Full Text] [Related]
33. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor.
Furukawa T; Takahashi M; Moriyama Y; Koike T; Kurokawa I; Shibata A
Ann Hematol; 1991 Feb; 62(1):22-4. PubMed ID: 1709572
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
37. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
38. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation.
Dreger P; Grelle K; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
Br J Haematol; 1993 Jan; 83(1):7-13. PubMed ID: 7679589
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
Iwase M; Yoshiya M; Kakuta S; Nagumo M
J Oral Maxillofac Surg; 1997 Aug; 55(8):836-40; discussion 841. PubMed ID: 9251612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]